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1. INTRODUCTION 
Alcohol related liver disease is the commonest liver disease in India1. 
At least 1 in 5 Indians is living with some kind of liver problem related to 
alcohol. Its incidence in India is on the raising trend2.It also remains a major 
etiological factor for cirrhosis worldwide.  WHO estimates 140 million 
people worldwide suffer from alcohol dependency causing damage to lives 
and economics3. 
Esophageal varices remain a serious complication in patients with 
alcoholic cirrhosis. Variceal bleeding is the second most common cause of 
mortality in patients with cirrhosis4. Development of esophageal varices in 
cirrhotics is 5-8% per year with 1 – 2% risk of bleeding. 30% of the patients 
bleed at the first time of diagnosis. Rupture of esophageal varices accounts 
for 10 – 30% of all cases of Upper Gastro Intestinal bleed with high 
mortality rate of 20%5. 
Currently as per recommendations all cirrhotic patients are advised to 
undergo screening by endoscopy at the time of diagnosis to identify those at 
high risk of bleeding varices and likely benefiting from primary prophylaxis. 
The above approach however imposes a significant burden on the endoscopy 
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units and also decreases patients compliance due to repeated testing. 
Moreover, in peripheral health centres endoscopy is not readily feasible6,7.  
Child Turcotte Pugh (CTP) score is a simple non invasive tool 
originally designed to assess the mortality in patients undergoing liver 
transplantation. It is now widely used in assessing the prognosis of patients 
with chronic liver disease (CLD). This non invasive tool can also be used to 
predict the occurrence and severity of esophageal varices on first encounter 
of the patients with alcoholic liver disease8. 
So in a tertiary referral centre like our institute – Madras Medical 
College, Chennai, with high patient inflow, these simple non endoscopic 
parameters based on the study will be useful to predict the incidence and 
severity of esophageal varices in patients with alcoholic liver disease. These 
parameters may also help the physicians practicing in rural areas where 
invasive endoscopic facilities are not readily feasible to initiate appropriate 
primary prophylaxis and further evaluation5. 
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2. AIM & OBJECTIVES 
 
The study on “A STUDY ON CHILD PUGH SCORE AS A NON 
ENDOSCOPIC PREDICTOR OF OESOPHAGEAL VARICES IN PATIENTS 
WITH ALCOHOLIC LIVER DISEASE” was carried out with the following 
objectives.  
 To study the age and sex incidence of esophageal varices in patients with 
alcoholic liver disease 
 To correlate Child Pugh Score with Oesophageal varices in patients with 
alcoholic liver cirrhosis. 
 To use the Child Pugh score value as a predictor for oesophageal varices 
and to calculate its value in assessing the varices severity. 
 To assess the significance of other non endoscopic variables for the 
presence of oesophageal varices. 
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3. REVIEW OF LITERATURE 
 
ALCOHOLISM: 
LITERATURE: 
 ALD represent the oldest form of liver injury known ever to 
mankind.Evidence suggests that fermented beverages existed at least 
as early as the Neolithic period (cir. 10,000 BC) 9. 
 Mr. Charles Lieber with his colleagues in 1975 published a 
groundbreaking research article in liver research, stating that alcohol 
per se is the prime factor for the greater prevalence of liver disease in 
alcoholic patients rather than dietary factors and malnutrition as 
thought earlier. This has led to the several decades of study on the 
harmful effects of alcohol and its liver metabolism. 
 Alcohol remains a major cause of liver disease worldwide1. 
 It is the WORLDS THIRD largest factor for the disease burden. 
 The harmful use of alcohol results in 2.5 million deaths each year 
most of the mortality being secondary to cirrhosis10.Its incidence in 
5 
 
India is on the increasing trend. Almost 1 in 5 Indians suffer from 
liver problems related to alcohol.  
 
RISK FACTORS FOR ALCOHOLIC LIVER DISEASE 
 1. Quantity and 2. Duration of alcohol intakeare the prime risk 
factors involved in the development of alcoholic liver disease10. The 
relationship between the amounts of alcohol consumption with the 
development of liver disease was not clearly linear. 
Figure 1: Risk factor and association of Alcoholic Liver Disease10
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 The risk to cirrhosis increases with the intake of >60–80g/day of 
alcohol in males and >20g/day in females for more than 10 years11, 12. 
Though the development of cirrhosis is seen in only 6-41% of the 
individuals11, 13. 
 On estimating the alcohol consumption it was found  that four ounce 
of wine, one beeror one ounce of 80% spirits all have same amount of 
alcohol(12 g)10. 
 The threshold to develop alcoholic liver disease was found to be 
higher in males, while females develops similar degrees of injury to 
the liver by taking significantly less quantity.This sex difference is the 
result from poorly understood body fat proportion, estrogen and effect 
of menstrual cycle and the metabolism of alcohol in the stomach due 
to varied gastric levels of alcohol dehydrogenase enzyme. One 
another factor identified is to the pattern of drinking. Drinking outside 
of meal times increases the risk of ALD by 2.7-fold14. Some 
researches define binge drinking as four drinks for females and five 
drinks for males in one sitting also shown to increase the risk of 
Alcoholic liver disease15,16. 
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Alcoholic liver disease is the term used to describe the spectrum of the 
disease related to acute and chronic alcoholism. 
The sequential changes are described in the following headings: 
 FATTY LIVER( ALCOHOLIC STEATOSIS) 
 ALCOHOLIC HEPATITIS 
 ALCOHOLIC CIRRHOSIS 
Figure 4:  SPECTRUM OF THE DISEASE20
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FATTY LIVER 
 
 Fatty liver is seen in approximately 90% of the individuals who drink 
greater than 60g of alcohol per day21, but may also occur in those 
who consume less22. Patients with uncomplicated fatty liver are 
usually asymptomatic with a self-limited course, and are reversible 
completely with abstinence after 4–6 weeks23. But, there are studies 
suggesting the progression to fibrosis and later to cirrhosis can occur 
in about 5–15% of the patients in spite of abstinence24,25.  
 
Figure 5: Histopathology of Liver17 
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 On a gross view, the liver is enlarged, yellow, greasy and firm witha 
smooth and glistening capsule.Microscopic picture of the liver shows 
microvesicular fat deposits in the cytoplasm initially followed later by 
macrovesicular deposits displacing nucleus to the periphery. 
 
ALCOHOLIC HEPATITIS: 
 It includes a spectrum of a disease ranging from mild to severe life 
threatening illness.It usually presents acutely in a background of 
patients with chronic liver disease.The true prevalence of the disease 
is not known.Study on the histological slides of the of the patient with 
ALD suggests as many as 10–35% of hospitalized alcoholic patients 
have features of alcoholic hepatitis26,27,28.Symptomatic usually are 
those with advanced liver disease and concomitant cirrhosis is seen in 
more than 50% of the patients, with superimposed acute 
decompensation. As per a study, patients even with a relatively mild 
presentation are at a high risk for progressive liver injury, with 
cirrhosis developing in up to 50% of the patients29, 30, especially in 
those who continue to abuse alcohol. 
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PATHOGENESIS OF ALCOHOLIC HEPATITIS 
 
 
 
 
 
 
 
Figure 6: Histopathology of Alcoholic Hepatitis17 
The histological feature of alcoholic hepatitis includes: 
 Hepatocellular necrosis with surrounding inflammatory infiltrate, 
predominantly polymorphs especially in the centrilobular zone. 
Presence of alcoholic hyaline or Mallory bodies (eosinophilic 
cytoplasmic inclusions representing aggregates of intermediate 
filaments-cytokeratin stained by Massons-Trichome or by immune 
peroxidase method). 
 FIBROSIS: Most cases are accompanied by fibrosis. 
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Usually begins in the perivenular31, 32and pericellular area producing 
a web-like or chicken wire like appearance termed as creeping 
fibrogenesis. 
 Alcoholic hepatitis manifests with a wide range of clinical features. 
Patients symptoms may range from entirely asymptomatic to fever, 
jaundice and abdominal pain mimicking acute abdomen. Portal 
hypertension, ascites or variceal bleeding may occur in the absence of 
cirrhosis. Recognition of clinical features is crucial to the initiation of 
effective and appropriate diagnostic and therapeutic strategy10. 
 
Figure 7: LABORATORY DIAGNOSIS OF ALCOHOLIC FATTY 
LIVER AND ALCOHOLIC HEPATITIS10 
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ALCOHOLIC CIRRHOSIS: 
 The term cirrhosis was coined by Laennec in 1818 due to the yellow 
tawny appearance of the liver due to the presence of fat lobules.It is 
derived from the greek word kirrhos=Tawny. Cirrhosis represents the 
most severe form of alcohol related liver injury. 
 On the gross appearance of the liver in the initial stages shows liver 
large,fatty weighing more than 2 kg studded with diffuse 
micronodular nodules(<3cms) resembling a Hob nail pattern 
(resemblance of the surface with the sole of an old-fashioned shoe 
having short nails with heads).Later the liver becomes shrunken and 
non-fatty. Collagen bridges are formed between portal tracts and 
central veins resulting in isolation of hepatocytes resulting in 
regenerating macrondular nodules. 
Figure 8: Histopathology of Cirrhosis of Liver17 
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Figure 9: Clinical Manifestations of Cirrhosis 
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Figure 10: COMPLICATIONS OF CIRRHOSIS10 
 
 
 
 
 
 
 
 
PORTAL HYPERTENSION: 
Development of portal hypertension heralds the onset of complications in 
patients with cirrhosis. 
ANATOMY OF THE PORTAL SYSTEM: 
 The liver has a dual blood supply from the portal vein and hepatic 
artery.The portal vein contributes to 2/3rd(75%) of the total hepatic 
blood flow.The portal vein was formed behind the neck of the 
pancreas atthe confluence of the superior mesenteric vein with the 
splenicvein at the level of the L2 vertebrae. The length of the main 
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portal vein ranges from 5.5 to 8 cm and its diameter approximates 1 
cm. Portal vein are valveless. The absence of valves in the portal 
circulation helps to accommodate high flow of blood at low pressure 
because of the low resistance.This allows for the measurementof 
portal venous pressure at any point along the system. 
 
Figure 11: ANATOMY OF PORTAL CIRCULATION 
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 Obstruction to the portal flow anywhere along its course results in 
elevation of portal pressure and portal hypertension.Portal 
hypertension is defined as the hepatic venous pressure gradient more 
than 5 mm Hg. Cirrhosis is the most common cause for sinusoidal or 
intrahepatic hypertension.Clinically significant portal hypertension is 
defined as a threshold portal pressure gradient of more than or equal 
to 10 mm Hg as it predicts the best in the development of 
complications of cirrhosis like  ascites. 
 
PATHOGENESIS OF PORTAL HYPERTENSION: 
 It is influenced by two factors. 
Increased resistance to     Vs   Increased  splanchnic blood flow. 
Intrahepatic blood flow     
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Figure 11: Pathogenesis of Portal Hypertension 
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Figure 12:COMPLICATIONS OF PORTAL HYPERTENSION 
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MECHANISM OF ASCITIC FORMATION IN CIRRHOSIS: 
 2 important factors leading to ascites are sinusoidal hypertension35, 36 
and sodium retention37.The development of cirrhosis requires a 
minimum portal pressure gradient of 12 mm Hg35, 36. 
MECHANISM OF ASCITIS IN CIRRHOSIS: 
3 THEORIES behind ascites:   
 Underfill theory 
 Overfill theory 
 Vasodilation theory(most accepted) 
Figure 13: Theory of Ascitis Formation In Cirrhosis 
 
 
 
 
 
 
 
 
 
  
Asc
cirr
inc
to 
sen
 
 
 
 
 
 
 
 
 
 
 
 
 
ites repre
hosis.Phy
ase of sm
become c
sitive bed
sents adv
sical exa
all ascites
linically 
side tool t
Fig
anced sta
minations
 and obes
detectabl
o demons
ure 14: G
ge of dec
 are rela
e patients
e.Shifting
trate ascit
rading o
ompensat
tively ins
.1500 ml 
 dullness 
es. 
f Ascitis
ion in pat
ensitive 
of fluid i
remains 
22
ients with
especially
s required
the most
 
 
 
 
 
23 
 
 
 Associated features: 
 Umblical hernia due to diastasis of rectus, abdominal and inguinal 
hernias.Peripheral edema due to hypoproteinemia and functional IVC 
obstruction due to the mechanical compression of IVC by the 
fluid.Hydrothorax –seen in 5-10% of the individuals with ascites39and 
is seen as right sided effusion in 85% of the individuals40, 41 and the 
mechanism is due to seepage of the ascitic fluid through a 
diaphragmatic rent. 
 
Fig.14:  Ascitic Fluid Characteristics 
 
 
 
 
 
 
 
 
 
 CHARACTERISTICS OF 
ASCITIC FLUID IN CIRRHOSIS: 
 Ascitic fluid is usually straw 
coloured 
 Transudate with very low 
protein content due to 
CAPILLARISATION of sinusoids 
making it less leaky to proteins. 
 Protein content is usually <3 
g/dL 
 SAAG ratio >1.1 g/Dl suggestive 
of sinusoidal hypertension 
 Specific gravity ‐1.010 
 Contains very few mesothelial 
cells, mononuclear cells 
(<100/mm3)and very few PMN. 
 Presence of Polymorphs in 
increased amount indicates 
secondary infection or SBP. 
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SPONTANEOUS BACTERIAL PERITONITIS: 
 It remains a serious complication of patients with ascites representing 
infection of ascitic fluid without an intra-abdominal source.It 
incidence is 30% in patients with ascites and accounts for 25% in 
hospital mortality.Presence of polymorphs more than 250/U L is 
required to make a diagnosis ascetic fluid of SBP38. Translocation of 
the gut flora through the intestine into the peritoneal cavity. Most 
common organisms include E.coli and other gram positive organisms 
of the gut flora10. Culture of the bacteria is negative in 45% of the 
cases but the yield can be increased by inoculating at the bedside. 
 
REFRACTORY ASCITIS42: 
             It is defined as that cannot be prevented neither mobilized from 
recurring by medical therapy.It is of two types: 
diuretic - resistant (ascites  not mobilized inspite of  maximal dose of 
diuretic) 
diuretic – intractable(presence of complications induced by diuretic that 
precludes an effective dose of diuretic). 
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HEPATIC ENCEPHALOPATHY45: 
Hepatic encephalopathy is the term that is used to describe 
thecomplex and variable reversible changes in neuropsychiatric status of the 
patients that complicate the liver disease.Itranges from clinically 
undetectable changes in the level of cognition to clinically obvious changes 
in behaviour, motor functions, intellect and consciousness. The exact 
pathogenesis of portal hypertension syndrome is not known. Porto– systemic 
shunting and hepatocellular failure remains the chief factors in the 
development of portal hypertension.Gut – derivedtoxins, such as ammonia 
escapes from detoxification of liver and impinges on the brain and are 
detoxified by astrocytes resulting in edema of the brain cells with its 
ultimate impact on the neuronal function. 
Figure 15: Pathogenesis of Hepatic Encephalopathy 
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Figure 17: Symptoms of Hepatic Encephalopathy 
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PORTO-SYSTEMIC COMMUNICATION: 
There are numerous connections between the portal andsystemic 
venous systems. Under conditions of high portal venous pressure, these 
porto-systemic connections may enlarge secondarily to collateral flow.  
The development of porto-systemic collaterals in case of portal hypertension 
leads to two basic mechanism: 
 (1) neo-angiogenesis and  
(2) dilatation of embryonic channels that are pre existing  between the 
portal and systemic circulations27, 28. 
Esophageal Varices are abnormally engorged submucosal veins in the lower 
part of esophagus. Variceal haemorrhage is a life-threatening complication 
seen in cirrhosis that develops once the HVPG exceeds 12 mm Hg.The 
major blood supply of esophagus is from the left gastric vein.The diameter 
normally is 1 mm which raise to 1-2 cms during portal hypertension. 
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Figure 20: LAYERS OF ESOPHAGUS45 
 
 
The intra epithelial veins are seen as red spots in endoscopy. The trunk 
arising from adventitial plexus serves as the source of large esophageal 
varices. A common site for oesophageal variceal rupture to occur is at the 
Gastro-esophagealjunction at the palisade zone – an area between the 
perforating zone of the oesophagus and the gastric zone).This area serves as 
a watershed area between the portal veins and the azygous, here the flow is 
bidirectional resulting in a turbulent flow leading to rupture frequently. 
After the initial diagnosis of cirrhosis the yearly risk of developing 
varices is 5-8% /year49, 50.  
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COMPLICATIONS OF ENDOSCOPY: 
The use of endoscopy has increased greatly in the recent years but has its 
own risk.Adverse events due to endoscopic procedures become unacceptable 
if endoscopy is not indicated. 
 “National Confidential Enquiry into Patient Outcome and Death 
report”-“scoping our practice”48 analyzed death  that occurred  in UK 
within 30 days of endoscopy done for therapeutic procedure. 
 “scoping our practice” viewed 1818 therapeutic endoscopies in 263 
patients with an analysis of events that related to complications and 
death. 
 They highlighted various inadequacies that resulted in complication 
and stated that there should be national guidelines to guarantee 
competent endoscopy. 
COMPLICATIONS OF ENDOSCOPY: 
 Risk of rupture of the organs 
 Risk of bleeding 
 Infections 
 Anesthesia related complications 
 Patients’ compliance. 
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CHILD –PUGHS SCORE: 
Dr. C.G. Child and Dr. J.G. Turcotte of the University of Michigan in 
196452first proposed a system for scoring inorder to estimate the surgical 
risk in patients recovered from UGI bleed who are candidates for porto-
systemic shunt. They considered 5 variables out of clinical experience: 
serum levels of albumin and bilirubin,ascites,hepatic encephalopathy and 
nutritional status and classified as best (A), moderate (B), or worse (C) 
prognosis. 
Figure 25: Dr. J.G. Turcotte 
 
 
 
 
 
 
 
• In 1973, Pugh et al. 53 modified this version by replacing  nutritional 
status with prothrombin time (PT) and  gave a score of 1 to 3 to each 
variables. 
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• Child-Pugh classification is the most commonly used scoring system 
to evaluate the prognosis of patients with cirrhosis of liver54.  
• Two out   of the fivevariables were subjective, while the rest of the 
three were laboratory.  
Figure 26: Child Pugh Score10 
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 Child Pugh calculation is a simple bedside prognostic measures in 
patients with alcoholic cirrhosis.It is a good predictor of outcome in 
patients with complications of portal hypertension.It predicts the 1 yr 
and 2 yr mortality in patients with alcoholic cirrhosis. 
 
In patients with cirrhosis,the 1yr and 2 yr mortality were found to be  
 Child Pugh class A(well compensated cirrhosis)-100 and 85% 
respectively. 
 Child Pugh class B(significant functional compromise) -80 and 60% 
respectively. 
 Child Pugh class C(decompensated)-45 and 35% respectively.  
 
Currently, numerous studies are published with the utility of Child Pugh 
score - A few mentioned below 
 To select the patients pre operatively for liver transplantation. 
 To assess for the hepatic resection in Patients with hepatocellular 
carcinoma. 
 Prognosis of the patients with hepatocellular carcinoma planned for 
radiotherapy. 
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 To predict for the presence of esophageal varices and its severity and 
the risk of rebleed. 
Figure 27: Primary Prophylaxis of Esophageal Varices 
 
 
 
 
 
 
 
 
 
 Our current approach should be targeted towards the preprimary 
prevention of the disease to prevent the dreaded complication of 
rupture of the varices that accounts for a significant mortality in 
patients with alcoholic cirrhosis. 
 Several studies are targeting to tackle the problem,by the search for 
parameters other than the invasive endoscopic procedure to target at 
the grassroot level. 
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 Clinical laboratory and non invasive parameters are under study, in 
search for effective non-endoscopic parameters for the presence of 
varices. 
 Child-Pugh score to assess the prognosis and mortality of the patients 
with alcoholic cirrhosis are now under study in the usefulness of the 
score to assess the severity and the presence of varices. 
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4. MATERIALS& METHODS 
DESIGN OF STUDY 
Time period of study –  March 2015 to August 2015(6 months) 
Age of patients - 18 years and above 
Gender of patients –Both Males& Females 
Place – Madras Medical College and Rajiv Gandhi Government General 
Hospital, Chennai. 
 
INCLUSION CRITERIA 
Age – 18 years or more 
Patients with alcoholic liver disease(Associated with significant intake of 
alcohol) 
 
EXCLUSION CRITERIA 
 Pregnancy. 
 Age <18 years. 
 Patients with liver disease due to causes other than alcohol(Infection, 
NASH, other hepatotoxins, etc.) 
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 Patients with alcoholic liver disease with previous history of varices, 
or upper gastro intestinal bleed or any therapeutic intervention for the 
same. 
 Patients with upper gastrointestinal bleed with no significant alcohol 
intake. 
 Patients with hematological disorders or patients on drugs(anti-
platelets, anti-coagulants or hepatotoxic drugs). 
 Patients with alcoholic liver disease with gastric varices. 
 Patients who were treated with b blockers either currently or in the 
past. 
 
SAMPLE SIZE 
The samples selected for this study were patients who came for 
treatment at Madras Medical College and Rajiv Gandhi Government General 
Hospital for alcoholic liver cirrhosis. Study group/study population was the 
number of patients had alcohol induced liver disease and on further 
evaluation and management in the Department of General Medicine, Madras 
Medical College and Rajiv Gandhi Government General Hospital. The 
sample size of 106 was calculated by analyzing with Power analysis test 
44 
 
with the prevalence rate of alcoholic liver disease as 20% in south India and 
found to be statistically significant2. 
 
ETHICS  
The study was performed after the approval of the institutional ethics 
committee of Madras Medical College and Rajiv Gandhi Government 
General Hospital. The procedure was performed in accordance with the 
ethical standard and photographs were taken with patients and their 
relatives’ full consent. 
 
INFORMED CONSENT 
All patients were enrolled into the study after getting informed & 
written consent. Proforma of informed& written consent is enclosed in 
annexure III. 
 The essence of consent comprised of the following: 
- Consent explaining risks and benefits of the study and need for 
UGI endoscopy in the evaluation of the disease (To assess 
oesophageal varices in Alcoholic liver disease). 
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- Also explaining that UGI endoscopy may just be an aid in 
diagnosis, not a manner in which the problem can be entirely fixed 
or cured. 
 
DATA RECORDING 
 Records from all the patients in the study group was collected and 
documented in the proforma framed for this study. Proforma used is attached 
as annexure I.  
 
All Patients in the study were subjected to, 
 
 In the study all the patients underwent a detailedhistory taking using 
the AUDIT Questionnaire(attached in annexure II). Though different 
questionnaires are available, AUDIT questionnaire had higher 
reliability.This 10 points questionnaire was proposed by WHO to 
avoid the ethnical and cultural bias. Patients with significant alcohol 
intake are included in the study after the history. Though the 
significant level of alcohol to cause the damage is not well 
46 
 
established,most of the researches signifies that the consumption of 
>30 g/day of alcohol is significant that is utilized in this study55. 
 
 Physical examination 
 Laboratory tests –Complete Hemogram, BT/CT/PT/INR, Blood 
Grouping, Liver Function Test, S. Albumin.  
 Non invasive imaging USG and Doppler 
 Upper Gastro intestinal endoscopy 
 Child Pugh score assessmentfor all patients  
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TECHNIQUE ADOPTED 
 
 Child Pugh Score Calculation for every patient and Comparison with 
UGI endoscopy findings of them. 
 Comparing other physical findings, blood and imaging parameters 
with the UGI endoscopy findings to assess its significance in the study 
conducted. 
 Physical findings – Pallor, Icterus, Spider naevi, Hepatic 
encephalopathy, Ascitis, Splenomegaly.  
 Blood Investigations – Hemoglobin, Platelet count, Total Bilirubin, 
S. albumin, INR (INR considered for comparison in my study 
instead of Prothrombin time prolongation, both for individual 
parameter comparison and for calculating Child Pugh Score 
because it is to be more reliable and standardized test comparing to 
Prothrombin time).  
 Ultrasonogram – liver and spleen size, Portal Vein diameter, 
ascitis. 
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STATISTICAL DATA ANALYSIS 
 
 For this study, historical, clinical,laboratory, endoscopic data and 
Child Pugh score charts were documented for all the 106 subjects under 
study, in the form of a proforma and computed into Microsoft excel 
spreadsheets and coded. All results were analyzed using SAS 9.2, SPSS 15.0 
which are commercially available statistical softwares. Descriptive and 
inferential statistical analysis had been carried out in the present study. 
Results on continuous measurements were presented as Mean + SD (Min-
Max) and results on categorical measurements were presented in Number 
(%). Significance was assessed at 5% level of significance. Independent 
sample test and paired sample T test (ANOVA) has been used to find the 
significance of study parameters on categorical scale between two or more 
groups after checking for normal distribution of all variables.  
LIMITATIONS 
-   Single center study may not reflect the general population, 
-  Possibility of observational bias in upper GI endoscopy and imaging 
since they were operator dependant.  
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5. OBSERVATION 
Total number of cases  : 106 
Parameters Studied  : 
 Age and gender epidemiological parameters. 
 Significance of the Child Pugh Score and its 
association with the evaluation of Esophageal 
varices. 
 Various Clinical features analyzed with esophageal 
varices. 
 Association of Laboratory parameters with 
esophageal varices. 
 Significance of USG measurement of Portal vein 
diameter with esophageal varices. 
 
All the above details were analyzed and tabulated in the master 
worksheet for comparison between individual cases and with published data. 
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AGE AND SEX INCIDENCE 
 Out of 106 patients studied, 44.4% were in the age group of 21 to 40 
years (Young adults) and 54.7% were in the middle age (41- 65 years) and 
0.9% belonged to senior citizens (> 65 years)56. And 35.8% belong to Child 
Pugh Score A and 52.8% belong to Child Pugh Score B and 11.4% belongs 
to Child Pugh Score C category. 
Table 1: AGE INCIDENCE WITH CHILD PUGH SCORE 
Age Child Pugh Score A 
Child Pugh 
Score B 
Child Pugh 
Score C Total 
Young 
Adults 
(21 – 40) 
28(59.6%) 17(36.2%) 2(4.2%) 47(44.4%) 
Middle age 
(41 – 65) 9(15.5%) 39(67.2%) 10(17.3%) 58(54.7%) 
Old age 
(≥ 65) 1(100%) 0(0%) 0(0%) 1(0.9%) 
Total 38(35.8%) 56(52.8%) 12(11.4%) 106 
 
In our study of 106 patients, most of the patients falls under middle age group of 
41-65 years(54.7%).majority of the patients belong to Child Pugh score B(52.8%). 
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Our study demonstrates that hepatic encephalopathy was seen in 8%of 
the individuals with no varices,34% of the patients with small varices and 
92% of the patients with large varices implying the increased incidence of 
hepatic encephalopathy at higher grades of varices. 
 
ASCITIS 
 
Table 9 
ASCITIS 
ESOPHAGEAL VARICES 
Total 
NO  
Varices 
Small varices 
(Gr I –II) 
Large Varices 
(Gr III-IV) 
 
N 
Count 12 59 3 74 
Percent 100.0% 84.3% 12.5% 69.8% 
RD 
Count 0 11 20 31 
Percent 0.0% 15.7% 83.3% 29.2% 
NRD 
Count 0 0 1 31 
Percent 0.0% 0.0% 4.2% 29.2% 
Total 
Count 12 70 24 106 
Percent 100.0% 100.0% 100.0% 100.0% 
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LABORATORY INVESTIGATIONS 
HEMOGLOBIN 
Table 11 N MEAN STD. DEVIATION 
HEMOGLOBIN 
(g/dl) 
NO 12 12.7167 0.81779 
I 24 12.5833 1.10755 
II 46 11.15 1.38848 
III 17 9.9471 1.53953 
IV 7 7.8857 1.43228 
TOTAL 106 11.2434 1.82465 
 
 
 In the study population,57 had no pallor(53.8%) and 49 had 
pallor(46.2%).comparing the presence of pallor to the presence of varices 
38.6% of patients with small varices (Grade I - II) had pallor and 91.70% of 
the patients with large varices (Grade III - IV) had pallor. From the study, it 
is seen that patients with higher degree of varices had pallor 
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PLATELET COUNT 
Table 12 N MEAN STD. DEVIATION 
PLATELET 
COUNT 
(LAKHS/CU.MM.) 
N 12 1.8567 0.60331 
I 24 1.1683 0.48668 
II 46 1.0563 0.26619 
III 17 0.8729 0.15608 
IV 7 0.5914 0.07819 
TOTAL 106 1.1801 0.49075 
 
In our study,mean platelet count in No varices group(1.8 L/cu.mm.), 
grade I (1.16L/cu.mm.), grade II (1.05 L/cu.mm.),grade III (0.87 L/cu.mm.), 
grade IV ( 0.59 L/cu.mm.) with a significant p value of <0.001 signifying 
thrombocytopenia as a marker for esophageal varices and its severity. 
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TOTAL BILIRUBIN 
Table 13 N MEAN STD. DEVIATION 
TOTAL BILIRUBIN 
(mg/dl) 
N 12 1.15 0.70903 
I 24 1.1792 0.52584 
II 46 1.9913 0.57497 
III 17 3.4 1.96977 
IV 7 4.5143 2.34693 
TOTAL 106 2.1047 1.45781 
 
 
Patients with higher grades of variceshad higher values of serum 
bilirubin. 
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S. ALBUMIN 
Table 14 N MEAN STD. DEVIATION 
S. ALBUMIN g/dl 
N 12 3.6417 0.1379 
I 24 3.5542 0.15874 
II 46 3.4174 0.21008 
III 17 3.2118 0.39032 
IV 7 2.8857 0.38483 
Total 106 3.4057 0.30608 
 
 
Patient with no varices group had a mean albumin of 3.64 g/dL, grade 
I (3.55 g/dL), grade II (3.42 g/d L), grade III (3.21 g/dl), and grade IV (2.89 
g/dl) indicating presence of hypoalbunminemia in higher grades of varices. 
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INR 
 
Table 15 N MEAN STD. DEVIATION 
INR (no unit) 
N 12 1.2667 0.25346 
I 24 1.4208 0.29924 
II 46 1.5717 0.28803 
III 17 2.1471 0.82395 
IV 7 2.8286 0.99785 
Total 106 1.6783 0.62091 
 
 
 
Patients with higher grades of varices had prolongation of INR 
implying clotting factor abnormality in patients with higher varices group. 
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ULTRASONOGRAM FINDINGS 
Table 16 N MEAN STD. DEVIATION 
PORTAL VEIN 
DIAMETER (in mm) 
N 12 11.3833 1.02144 
I 24 12.1542 0.81773 
II 46 13.1261 0.94197 
III 17 14.6647 1.49246 
IV 7 16.5286 2.25663 
TOTAL 106 13.1802 1.72673 
 
The relationship of portal vein diameter to the presence of varices 
shows mean PVD in the No varices group (11.38), gr I(12.15), gr II(13.12), 
gr III (14.66), gr IV ( 16.53) with a significant p value of < 0.001 implying a 
significant corelationship of portal venous diameter to the presence of 
varices and its severity. 
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CHILD PUGH SCORE 
 
38 out of 106 were in Class A (35.8%). Of which 23.7% had no 
varices, 71.1% had small varices and 5.3% of patients had large varices.56 
out of 106 were in Child Pugh Class B (52.8%), of which 5.4% had no 
varices, 75% had small varices and 19.6% had large varices.12 out of 106 
were in Child Pugh Class C (11.3%), of which 91.7% had large varices, 
while small varices were found in 8.3% of the individuals indicating the 
presence of varices and its severity to Child Pugh score. 
 
CHILD PUGH SCORE VS ESOPHAGEAL VARICES 
Table 17 
ESOPHAGEAL VARICES 
TOTAL NO  
VARICES 
SMALL 
VARICES 
(GR I –II) 
LARGE 
VARICES 
(GR III-
IV) 
CHILD 
PUGH 
SCORE 
A 
COUNT 9 27 2 38 
PERCEMT 23.7% 71.1% 5.3% 100.0% 
B 
COUNT 3 42 11 56 
PERCENT 5.4% 75.0% 19.6% 100.0% 
C 
COUNT 0 1 11 12 
PERCENT 0.0% 8.3% 91.7% 100.0% 
TOTAL 
COUNT 12 70 24 106 
PERCENT 11.3% 66.0% 22.6% 100.0% 
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6. DISCUSSION 
 
 Our study was conducted in patients with alcoholic liver disease with 
cirrhosis of liver to study the Child-Pugh score as a non-endoscopic 
predictor for the presence of esophageal varices and its role in assessing the 
variceal severity in the prediction of esophageal varices. Our study 
population included 106 patients admitted with liver disease diagnosed 
either by clinical, laboratory or sonographical methods. In all patients under 
study detailed history was taken, basic laboratory investigations and 
ultrasound was done. Patients are then undertaken for endoscopy to screen 
for varices after ruling out other causes for cirrhosis.Analysis was then made 
to correlate between the Child-Pugh score of the patients with the degree and 
severity of the esophageal varices using chi square test (ANOVA). Our 
study also included other parameters that are indicators for varices in 
patients with alcoholic cirrhosis.Following were the observation made from 
our study. 
Age distribution: Out of the 106 patients majority were in the age group of 
41-65 years (54.7%), with a mean age group of 43.2 years and belongs to the 
Child Pugh score B(52.8%).In our study 88.7% had varices and 11.3% had 
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no varices. In the study, majority of the patients with varices fall in the 
middle age group comparable to the previous study, Arul Prakash 
sarangapani, Chitra Shanmughamet al57. 
Sex distribution: In our study 101 out of 106 were males(95.3%) and 5 
were females(4.7%). 
Clinical Findings:In the study evaluation of the clinical signs out of the 106 
patients 57 had no pallor(53.8%) and 49 had pallor(46.2%).comparing the 
presence of pallor to the presence of varices 38.6% of patients with small 
varices (Grade I - II) had pallor and 91.70% of the patients with large varices 
(Grade III - IV) had pallor. From the study,it is seen that patients with higher 
degree of varices had pallor comparable to the earlier study, Arul Prakash 
Sarangapani, ChitraShanmugham,et al57. 
Icterus was absent in 81 of the patients(76.4%) and present in 25 of 
the patients(23.6%).In patients with small varices, icterus was present in 
8.60% of the individuals while in large varices75% had icterus. From the 
study the presence of icterus correlates with a higher degree of varices. 
Spider naevi as a clinical sign was present in 13 patients(12.3%). With 
a incidence of 54.20% in patients with large varices. So from the study the 
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presence of spider nevi indicates severity of varices in patients with 
alcoholic cirrhosis. 
On the comparison of the presence of hepatic encephalopathy with the 
esophageal varices in the study,49 patients were in the different grades of 
hepatic encephalopathy (46.2%). Of which majority of the individuals 
(44.3%) were in grade I-II and 1.9% of the patients were in grade III - IV 
hepatic encephalopathy.43.4% of the patients with small varices had grade I-
II hepatic encephalopathy compared to 91.7% of the patients with large 
varices.8.3% of the patients with large varices were in advanced (grade III - 
IV) stages of hepatic encephalopathy proving that presence of hepatic 
encephalopathy correlates with higher degree of varices. 
On comparing the grading of ascitis with the severity of varices, out 
of the 106,69.8% had no ascitis and 30.1% had ascitis. In patients with small 
varices 84.3% had no ascitis while 15.7% had ascitis responsive to diuretics. 
In patients with large varices,12.5%were normal while 83.3% had ascitis 
responsive to diuretics and 4.2% had ascitis that was resistant to diuretic. 
From the study, ascitis is not a reliable marker for varices but the presence 
higher grades of ascitis indicates larger varices in patients with alcoholic 
cirrhosis. 
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 In the study, splenomegaly was seen in 23% of the individuals while 
77% had no splenomegaly. In patients with grade II varices ,8.7% had 
splenomegaly, and in grade III  76% had splenomegaly while it is a constant 
finding in patients with grade iv varices group implying the presence of 
splenomegaly correlates with the presence of larger varices in patients with 
alcoholic cirrhosis.The results are comparable to the national study,Arul 
Prakash Sarangapani, ChitraShanmugham,et al57. 
Laboratory Parameters: The mean Hemoglobin level in No varices group 
– 12.72 g/dl, Grade I varices – 12.58 g/dl, Grade II varices – 11.15g/dl, 
Grade III varices – 9.95 g/dl and Grade IV varices – 7.89 g/dl indicating 
patients with higher grades of varices have predominantly lower 
Hemoglobin. 
 The mean levels of Serum albumin in No varices – 3.64 g/dl, Grade I 
varices group – 3.55 g/dl, Grade II varices – 3.42 g/dl, Grade III varices – 
3.21 g/dl and Grade IV – 2.89 g/dl implying hypoalbuminemia in higher 
grades of Esophageal varices. 
 The mean INR in No varices – 1.27, Grade I varices group – 1.42 
Grade II varices – 1.57, Grade III varices – 2.15 and Grade IV – 2.83 with 
increased incidence of clotting factor abnormality with higher grades of 
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Esophageal varices. The values are comparable to the previous study, 
D.LaBreque, A.G.Khan, S.K.Sarinet al58.  
 The mean Platelet counts in No varices group – 1.8 lakh/cumm, Grade 
I varices group – 1.16 lakh/cumm, Grade II varices – 1.05 lakh/cumm, 
Grade III varices – 0.87 lakh/cumm and Grade IV – 0.59 lakh/cumm with 
significant p value of < 0.001. From the study, presence of 
thrombocytopenia is a marker for the presence of esophageal varices and 
also indicates the severity of varices comparable to the study, Arul Prakash 
sarangapani, ChitraShanmugham,et al57. D.La Breque, A.G.Khan, 
S.K.Sarinet al58.  
Ultra Sonography: USG findings in patients with alcoholic liver disease 
where the portal vein diameter is assessed, the mean values were No varices 
group – 11.38 mm, Grade I varices group – 12.95 mm, Grade II varices – 
13.12 mm, Grade III varices – 14.66 mm and Grade IV – 16.52 mm with 
significant p value of < 0.001. So our study proves that portal vein diameter 
can be used to predict the presence of esophageal varices and its severity in 
patient with alcoholic cirrhosis comparable to the earlier study, D. La 
Breque, A.G.Khan, S.K.Sarinet al58.  
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Child Pugh Score Assessment:Comparing the Child Pugh Score with the 
Esophageal Varices shows 38 out of 106 were in Class A (35.8%). Of which 
23.7% had no varices, 71.1% had small varices and 5.3% of patients had 
large varices. 
56 out of 106 were in Child Pugh Class B (52.8%), of which 5.4% had 
no varices, 75% had small varices and 19.6% had large varices. 
12 out of 106 were in Child Pugh Class C (11.3%), of which 91.7% 
had large varices, while small varices were found in 8.3% of the individuals.  
The study concludes that Child Pugh Score can be used as an effective 
predictor for varices and the severity of the varices as comparable to the 
earlier study, Arul Prakash Sarangapani, ChitraShanmugham,et al57, D.La 
Breque, A.G.Khan, S.K.Sarinet al58.  
 
 
 
 
 
 
 
75 
 
7. SUMMARY 
The following results were obtained from our study: 
 Majority of the patients with alcoholic cirrhosis belongs to the middle 
age group and falls under Child Pugh score B. 
 In our study, alcoholic cirrhosis of liver was more common in males 
when compared to females.This age difference can be due to lower 
incidence of alcohol in females in South India. 
 Majority of the patients with large varices had pallor, icterus,spider 
naevi and splenomegalysignifying that the above parameters can be 
taken as markers for the presence of large varices in patients with 
alcoholic cirrhosis. 
 Most of the patients with varices had hepatic encephalopathy of which 
majority falls under grade I-II.Advanced stages of hepatic 
encephalopathy are seen in patients with large varices. 
 Ascitis was commonly seen in patients with large varices and most of 
the cases were responsive to diuretics while a small percentage of 
cases in the large varices group were diuretic resistant. 
 Patients with higher degree of varices had low hemoglobin, 
hypoalbuminemia and prolongation of INR. 
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 In the study, analysis on the platelet count had a significant p value 
implying Thrombocytopenia as an indicator for the presence of 
esophageal varices and also correlates with its severity in patients with 
alcoholic cirrhosis. 
 Ultrasound assessment of portal venous diameter in the study 
population showed a significant p value correlating its association 
with the presence of esophageal varices. 
 Child Pughs score had a significant p value and showed the 
significance of the comparison of the score with the presence of 
esophageal varices and its severity. Majority of the patients fall under 
Child Pugh Score B.Patients with higher score had higher grades of 
varices. In our study, a significant proportion of patients falling under 
Child Pugh score A also had varices signifying the need for primary 
prophylaxis at the initial stages. 
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8. CONCLUSION 
 
Alcoholic liver disease is on an alarming rising trend worldwide.Variceal bleed 
carries a significant morbidity and mortality in patients with alcoholic liver disease. 
Hence, early detection of varices is of prime importance. But to detect varices currently 
we rely upon endoscopy and it remains the only cornerstone which has added 
disadvantages of reduced availability,less patient compliance,increased risk of 
complications and its mortality,delay in the treatment and increased health care costs.To 
alleviate these factors especially in a peripheral setup with reduced accessibility for 
endoscopic services,use of other non-invasive parameters will be helpful to overcome the 
need.So, in the search for different non endoscopic parameters that can be relied upon,the 
present study shows a significant correlation of Child Pugh score with the presence of 
esophageal varices and also correlates with the severity of the varices. Other parameters 
like the platelet count, portal vein diameter also had a significant association with the 
presence of esophageal varices. The study shows majority of the patients with Child Pugh 
score B and C had varices while in our study, Child Pugh score A also had a significant 
proportion of varices(76.4%) imposing the search for varices from the grassroot level and 
the need for timely intervention. 
The limitation of the study is that it involves a smaller population compared to the 
disease burden and results are based on the study conducted in a single institute.The 
study also had inter-observer variation on the endoscopy findings. So it is recommended 
to conduct the study in large,multicentric trials to verify the result. 
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10. ANNEXURES 
ANNEXURE – I 
“A STUDY ON CHILD PUGH SCORE AS A NON ENDOSCOPIC   PREDICTOR FOR 
ESOPHAGEAL VARICES IN PATIENTS WITH ALCOHOLIC DISEASE” 
 
QUESTIONAIRE 
 
PATIENT DETAILS: 
Name:         Age:      Sex:     
 
IP No. : 
 
ON ADMISSION: 
Main Complaints : 
H/o jaundice       
H/o abdominal distension  
H/O abdominal pain 
H/o pedal oedema 
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H/o reduced urine output, 
H/O constipation,diarrhoea 
H/o breathlessness 
H/o orthopnoea/paroxysmal nocturnal dyspnea 
H/o haemetemesis 
H/o melena 
H/o  seizures 
H/o altered sensorium 
H/o altered sleep pattern 
H/o chest pain 
H/o fever 
H/o cough,sputum   
H/o intake of any drugs 
H/o recent blood transfusions or injections. 
 
Co – Morbid Illness    : 
Significant Past History  : 
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CLINICAL EXAMINATION: 
Pulse :           BP : 
RR :            Temp: 
GENERAL EXAMINATION: 
Pallor,        
Icterus,        
Cyanosis,        
Clubbing,      
Generalized lymyphadenopathy,  
Pedal or presacral edema. 
Signs of liver cell failure:  
Parotidomegaly, Leuconychia, Gynaecomastia, Duputyrens contracture, Palmar 
erythema, Spidernaevi, testicular atrophy. 
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SYSTEMIC EXAMINATION: 
Cardiovascular System:           
Respiratory System: 
Abdominal Examination: 
Central Nervous System: 
INVESTIGATIONS : 
Complete Hemogram 
Hemoglobin: 
Total Count/ Differential Count: 
Platelet Count: 
Hematocrit: 
Complete Liver Function Test 
Total Bilirubin: 
Direct/Indirect Bilirubin: 
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SGOT/SGPT: 
Serum ALP: 
Total Protein: 
Serum Albumin: 
Albumin/Globulin ratio: 
Prothrombin Time/INR: 
Bleeding time/Clotting time: 
Blood Grouping & Rh typing: 
Viral Markers: 
Upper Gastro Intestinal Endoscopy: 
Child Pugh Score: 
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ANNEXURE – II 
AUDIT QUESTIONNAIRE 
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ANNEXURE – III 
PATIENT CONSENT FORM 
Study Detail : “A STUDY ON CHILD PUGH SCORE AS A NON-ENDOSCOPIC 
PREDICTOR OF OESOPHAGEAL  VARICES IN PATIENTS 
WITH ALCOHOLIC LIVER DISEASE” 
Study Centre : Rajiv Gandhi Government General Hospital, Chennai. 
Patient’s Name :  
Patient’s Age :  
In Patient Number :  
 
Patient may check (☑) these boxes 
I confirm that I have understood the purpose of procedure for the above study. I have the  
opportunity to ask question and all my questions and doubts have been answered to my  
complete satisfaction. 
 
 
I understand that my participation in the study is voluntary and that I am free to withdraw  
at any time without giving reason, without my legal rights being affected. 
 
 
I understand that sponsor of the clinical study, others working on the sponsor’s behalf, 
the ethical committee and the regulatory authorities will not need my permission to look  
at my health records, both in respect of current study and any further research that may  
be conducted in relation to it, even if I withdraw from the study I agree to this access.  
However, I understand that my identity will not be revealed in any information released 
to third parties or published, unless as required under the law. I agree not to restrict the  
use of any data or results that arise from this study. 
 
 
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I agree to take part in the above study and to comply with the instructions given during  
the study and faithfully cooperate with the study team and to immediately inform the  
study staff if I suffer from any deterioration in my health or well being or any unexpected  
or unusual symptoms. 
 
I hereby consent to participate in this study 
 
 
 
I hereby give permission to undergo complete clinical examination and diagnostic tests  
including hematological, biochemical, radiological tests. 
 
 
 
Signature/thumb impression   Signature of Investigator 
 
Patient’s Name and Address:   Study Investigator’s Name: Dr. SINDHU.P 
 
 
 
 
 
 
 
 
 
92 
 
INFORMATION SHEET 
We are conducting a study on  
“A  STUDY  ON  CHILD  PUGH  SCORE  AS  A  NON‐ENDOSCOPIC  PREDICTOR  OF 
OESOPHAGEAL VARICES  IN PATIENTS WITH ALCOHOLIC LIVER DISEASE” among 
patients attending Rajiv Gandhi Government General Hospital, Chennai and  for 
that your specimen may be valuable to us. 
The purpose of this study is  
1.  To use Child Pugh  Score  as  an  alternative non  invasive  indicator  for 
oesophageal varices in patients with alcoholic liver disease.  
We are  selecting  certain  cases and  if you are  found eligible, we may be 
using  8ml  of  blood  sample  to  be  collected;  in  EDTA  for  Complete  hemogram, 
Complete  Liver  function  test and Prothrombin  time/INR will be  taken. We also 
need to take an USG abdomen and perform UGI Endoscopy to assess varices. 
The privacy of the patients in the research will be maintained throughout 
the  study.  In  the  event  of  any  publication  or  presentation  resulting  from  the 
research, no personally identifiable information will be shared. 
Taking part  in  this  study  is voluntary. You are  free  to decide whether  to 
participate in this study or to withdraw at any time; your decision will not result 
in any loss of benefits to which you are otherwise entitled. 
The results of the special study may be intimated to you at the end of the 
study period or during the study if anything is found abnormal which may aid in 
the management or treatment. 
 
 
Signature of Investigator     |     Signature of Participant 
 
 
Date  : 
Place  : 
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ANNEXURE – IV 
TAMIL CONSENT FORM 
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ANNEXURE – V 
ETHICAL COMMITTEE APPROVAL 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
100 
 
11. PLAGIARISM DIGITAL REPORT & RECEIPT  
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